lunes, 20 de octubre de 2025

Merck rolls out some showstoppers at a major cancer conference. Its future may depend on them ESMO provides a look at key treatments the company hopes can help replace Keytruda revenue

https://www.statnews.com/2025/10/20/merck-keytruda-esmo-bladder-cancer/

No hay comentarios: